132 related articles for article (PubMed ID: 32914320)
1. Tricked by transient ischemic dilation: A case of hypertrophic cardiomyopathy.
Pristera N; Bhargava A
J Nucl Cardiol; 2021 Oct; 28(5):2415-2418. PubMed ID: 32914320
[No Abstract] [Full Text] [Related]
2. Direct imaging of myocardial ischaemia with [18F]fluorodeoxyglucose on exercise PET in hypertrophic cardiomyopathy.
Yamano M; Kawasaki T; Sugihara H
Heart; 2009 Jul; 95(13):1051. PubMed ID: 19525255
[No Abstract] [Full Text] [Related]
3. Postischemic stunning in apical hypertrophic cardiomyopathy.
Askew JW; Umfrid RP
J Nucl Cardiol; 2005; 12(2):231-3. PubMed ID: 15812380
[No Abstract] [Full Text] [Related]
4. Marked multi-distribution myocardial ischemia in a patient with hypertrophic cardiomyopathy and no obstructive coronary artery disease.
Chan N; Kataria V; Delphin J; Auerbach A; Makaryus JN
J Nucl Cardiol; 2020 Apr; 27(2):695-697. PubMed ID: 30719657
[No Abstract] [Full Text] [Related]
5. Hypertrophic cardiomyopathy in the young: another form of ischemic cardiomyopathy?
Botvinick EH; Dae MW; Krishnan R; Ewing S
J Am Coll Cardiol; 1993 Sep; 22(3):805-7. PubMed ID: 8354815
[No Abstract] [Full Text] [Related]
6. Paroxysmal atrial fibrillation as a cause of potentially lethal ventricular arrhythmia with myocardial ischemia in hypertrophic cardiomyopathy--a case report.
Suzuki M; Hirayama T; Marumoto K; Okayama H; Iwata T
Angiology; 1998 Aug; 49(8):653-7. PubMed ID: 9717897
[TBL] [Abstract][Full Text] [Related]
7. Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by
Yalçin H; Valenta I; Yalçin F; Corona-Villalobos C; Vasquez N; Ra J; Kucukler N; Tahari A; Pozios I; Zhou Y; Pomper M; Abraham TP; Schindler TH; Abraham MR
Am J Cardiol; 2016 Dec; 118(12):1908-1915. PubMed ID: 27771003
[TBL] [Abstract][Full Text] [Related]
8. Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy.
Lu DY; Yalçin H; Sivalokanathan S; Greenland GV; Vasquez N; Yalçin F; Zhao M; Valenta I; Ganz P; Pampaloni MH; Zimmerman S; Schindler TH; Abraham TP; Abraham MR
J Nucl Cardiol; 2020 Dec; 27(6):2031-2043. PubMed ID: 30456498
[TBL] [Abstract][Full Text] [Related]
9. Effects of diltiazem on myocardial perfusion abnormalities during exercise in patients with hypertrophic cardiomyopathy.
Sugihara H; Taniguchi Y; Ito K; Terada K; Matsumoto K; Kinoshita N; Azuma A; Ushijima Y; Maeda T; Nakagawa M
Ann Nucl Med; 1998 Dec; 12(6):349-54. PubMed ID: 9972372
[TBL] [Abstract][Full Text] [Related]
10. Subendocardial ischemia in hypertrophic cardiomyopathy.
Kawasaki T; Sugihara H
J Cardiol; 2014 Feb; 63(2):89-94. PubMed ID: 24268421
[TBL] [Abstract][Full Text] [Related]
11. Severe ischaemia on SPECT myocardial perfusion imaging secondary to microvascular dysfunction and apical hypertrophic cardiomyopathy.
Russo RR; Emmett L; Mansberg R; Fung KC
Clin Nucl Med; 2010 Dec; 35(12):937-40. PubMed ID: 21206225
[No Abstract] [Full Text] [Related]
12. Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact.
Aguiar Rosa S; Rocha Lopes L; Fiarresga A; Ferreira RC; Mota Carmo M
Microcirculation; 2021 Jan; 28(1):e12656. PubMed ID: 32896949
[TBL] [Abstract][Full Text] [Related]
13. Gated single-photon emission computed tomography detects subendocardial ischemia in hypertrophic cardiomyopathy.
Kawasaki T; Akakabe Y; Yamano M; Miki S; Kamitani T; Kuribayashi T; Sugihara H
Circ J; 2007 Feb; 71(2):256-60. PubMed ID: 17251677
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic changes as a marker of improved subendocardial ischemia in a patient with hypertrophic cardiomyopathy.
Kawamata H; Kawasaki T; Kamitani T; Yoshioka K; Matoba S; Sugihara H
J Electrocardiol; 2018; 51(5):895-897. PubMed ID: 30177336
[TBL] [Abstract][Full Text] [Related]
15. Positron-emission tomography myocardial blood flow quantification in hypertrophic cardiomyopathy.
Sciagrà R
Q J Nucl Med Mol Imaging; 2016 Dec; 60(4):354-61. PubMed ID: 27611709
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Myocardial Ischemia Detected by Single-Photon Emission Computed Tomography in Children with Hypertrophic Cardiomyopathy.
Ziolkowska L; Boruc A; Sobielarska-Lysiak D; Grzyb A; Petryka-Mazurkiewicz J; Mazurkiewicz Ł; Brzezinska-Rajszys G
Pediatr Cardiol; 2021 Apr; 42(4):960-968. PubMed ID: 33687492
[TBL] [Abstract][Full Text] [Related]
17. Positrons, protons, and pulse waves: Multimodality characterization of newly diagnosed hypertrophic cardiomyopathy.
Al-Sabeq B; Soliman A; Chamsi-Pasha M; Shah DJ; Al-Mallah M
J Nucl Cardiol; 2020 Dec; 27(6):2412-2416. PubMed ID: 31898000
[No Abstract] [Full Text] [Related]
18. Myocardial ischemia on thallium scintigraphy in hypertrophic cardiomyopathy: predictor of sudden cardiac death.
Haley JH; Miller TD
Circulation; 2001 Sep; 104(13):E71-1. PubMed ID: 11571257
[No Abstract] [Full Text] [Related]
19. Diagnostic performance of ultrasonic tissue characterization for subendocardial ischaemia in patients with hypertrophic cardiomyopathy.
Kawasaki T; Yamano M; Sakai C; Harimoto K; Miki S; Kamitani T; Sugihara H
Eur Heart J Cardiovasc Imaging; 2013 Aug; 14(8):790-6. PubMed ID: 23221313
[TBL] [Abstract][Full Text] [Related]
20. Transient ischemic attack with apical hypertrophic cardiomyopathy.
Ceyhan C; Tekten T; Onbaşili OA; Ercan E
Jpn Heart J; 2003 Mar; 44(2):285-9. PubMed ID: 12718490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
